Menu Menu

ADMA    Adma Biologics Inc    1368514    
Income Statement
Revenue 119,839,000
Net Income 35,909,000
Profit Margin 29.96%

Balance Sheet
Current Assets 318,193,000
Assets 390,618,000
Current Liabilities 44,891,000
Liabilities 158,728,000
Equity 231,890,000
Shares Out 233,083,000

Cash Flow Statement
Operating Cash Flow 68,456,000
Investing Cash Flow -5,825,000

Market Analysis
Market Cap 4,370,302,500
Price 16.02
BVPS 0.99
PB 16.10
EPS 0.14
PE 133.35
PS 9.12
FCF 62,631,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/28 -0.08
Apr May Jun
5/09 0.08
Jul Aug Sep
8/08 0.13
Oct Nov Dec
11/7 0.15

Find a discrepancy? The most accurate way to find company fundamental data is to view ADMA documents filed with the SEC.


ADMA Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: